<DOC>
	<DOCNO>NCT02315105</DOCNO>
	<brief_summary>The purpose study find safety effectiveness Laparoscopic Greater Curvature Plication ( LGCP ) procedure patient obesity relate problem diabetes , hypertension , high cholesterol , mild obstructive sleep apnea , joint problem . LGCP less invasive weight loss surgery procedure weight loss surgery possible few risk procedure weight loss surgery . LGCP consider experimental procedure study do look long-term outcome .</brief_summary>
	<brief_title>Resolution Comorbidities &amp; Safety Efficacy Greater Curvature Plication Obese Patients</brief_title>
	<detailed_description>LGCP procedure stomach fold inwards capacity hold amount food decrease . This do general anesthesia . The operation take hour do laparoscopically . Laparoscopic approach entail place 4-5 small incision abdomen around umbilicus fill abdomen CO2 small tube call Trocars . help life abdominal wall create space surgeon carry his/her work use long instrument thickness similar regular lead pencil . The attachment stomach spleen free outside fold inside stitch keep folding . To ensure surgeon obstruct passage stomach , tube place stomach time creation fold checked end procedure camera stomach place mouth ensure desire outcome achieve . At conclusion procedure , skin close absorbable suture adhesive tape apply skin . The patient recovers recovery room hour half prior come room hospital . The post operative visit 7 day procedure . During visit , medical information obtain include information medication . There follow 3-10 surgery . These visit may include : - obtain medical information patient , include medical condition medication - Checking patient 's weight - Blood test - Endoscopic evaluation stomach necessary . The timing visit follow : Visit 3 : 1 month surgery Visit 4 : 3 month surgery Visit 5 : 6 month surgery Visit 6 : 12 month surgery Visit 7 : 18 month surgery Visit 8 : 24 month surgery Visit 9 : 30 month surgery Visit 10 : 36 month surgery The study three ( 3 ) year ( 36 month ) include follow visit .</detailed_description>
	<mesh_term>Obesity , Morbid</mesh_term>
	<criteria>1 . Subject willing give consent comply evaluation treatment schedule 2 . 18 65 year age 3 . Have BMI &gt; 30 one significant comorbid medical condition generally expect improve , reverse , resolve weight loss . condition include limited : Hyperlipidemia Type 2 diabetes Mild Obstructive Sleep Apnea Hypertension Osteoarthritis hip knee 4 . Agree refrain type weightloss drug ( prescription OTC ) elective procedure would affect body weight duration trial 5 . HbA1C &lt; 11 % 6 . For subject Type 2 Diabetes , antidiabetic medication regimen complex oral metformin plus one oral sulfonylurea plus daily insulin injection . 7 . Ability selfpay procedure follow .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>